-
1
-
-
0037471691
-
On the origins of cells: A hypothesis for the evolutionary transitions from abiotic geochemistry to chemoautotrophic prokaryotes, and from prokaryotes to nucleated cells
-
Martin W, Russell MJ. On the origins of cells: A hypothesis for the evolutionary transitions from abiotic geochemistry to chemoautotrophic prokaryotes, and from prokaryotes to nucleated cells. Philos Trans R Soc Lond, B, Biol Sci. 2003; 358:59–83.
-
(2003)
Philos Trans R Soc Lond, B, Biol Sci.
, vol.358
, pp. 59-83
-
-
Martin, W.1
Russell, M.J.2
-
2
-
-
84860574815
-
Iron sensing and signalling
-
Evstatiev R, Gasche C. Iron sensing and signalling. Gut. 2012; 61:933–952.
-
(2012)
Gut.
, vol.61
, pp. 933-952
-
-
Evstatiev, R.1
Gasche, C.2
-
3
-
-
84942357964
-
Pathogens, metabolic adaptation, and human diseases—An iron-thrifty genetic model
-
Pietrangelo A. Pathogens, metabolic adaptation, and human diseases—An iron-thrifty genetic model. Gastroenterology. 2015; 149:834–838.
-
(2015)
Gastroenterology.
, vol.149
, pp. 834-838
-
-
Pietrangelo, A.1
-
4
-
-
79954642381
-
Advances in metal-induced oxidative stress and human disease
-
Jomova K, Valko M. Advances in metal-induced oxidative stress and human disease. Toxicology. 2011; 283:65–87.
-
(2011)
Toxicology.
, vol.283
, pp. 65-87
-
-
Jomova, K.1
Valko, M.2
-
5
-
-
84885768132
-
Systemic iron homeostasis
-
Ganz T. Systemic iron homeostasis. Physiol Rev. 2013; 93:1721–1741.
-
(2013)
Physiol Rev.
, vol.93
, pp. 1721-1741
-
-
Ganz, T.1
-
7
-
-
0038481149
-
Iron, lipocalin, and kidney epithelia
-
Yang J, Mori K, Li JY, Barasch J. Iron, lipocalin, and kidney epithelia. Am J Physiol Renal Physiol. 2003; 285:F9–18.
-
(2003)
Am J Physiol Renal Physiol.
, vol.285
, pp. F9-18
-
-
Yang, J.1
Mori, K.2
Li, J.Y.3
Barasch, J.4
-
8
-
-
0035793856
-
An iron-regulated ferric reductase associated with the absorption of dietary iron
-
McKie AT, Barrow D, Latunde-Dada GO, et al. An iron-regulated ferric reductase associated with the absorption of dietary iron. Science. 2001; 291:1755–1759.
-
(2001)
Science.
, vol.291
, pp. 1755-1759
-
-
McKie, A.T.1
Barrow, D.2
Latunde-Dada, G.O.3
-
9
-
-
0030763856
-
Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene
-
Fleming MD, Trenor CC, III, Su MA, et al. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet. 1997; 16:383–386.
-
(1997)
Nat Genet.
, vol.16
, pp. 383-386
-
-
Fleming, M.D.1
Trenor, C.C.2
Su, M.A.3
-
10
-
-
0030755366
-
-
Cloning and characterization of. a mammalian proton-ion transporter
-
Gunshin H, Mackenzie B, Berger UV, et al. Cloning and characterization of. a mammalian proton-ion transporter. Nature. 1997; 388:482–488.
-
(1997)
Nature.
, vol.388
, pp. 482-488
-
-
Gunshin, H.1
Mackenzie, B.2
Berger, U.V.3
-
11
-
-
18244399587
-
Slc11a2 is required for intestinal iron absorption and erythropoiesis but dispensable in placenta and liver
-
Gunshin H, Fujiwara Y, Custodio AO, et al. Slc11a2 is required for intestinal iron absorption and erythropoiesis but dispensable in placenta and liver. J Clin Invest. 2005; 115:1258–1266.
-
(2005)
J Clin Invest.
, vol.115
, pp. 1258-1266
-
-
Gunshin, H.1
Fujiwara, Y.2
Custodio, A.O.3
-
12
-
-
84986216663
-
Intestinal brush-border Na+/H+ exchanger-3 drives H+-coupled iron absorption in the mouse
-
Shawki A, Engevik MA, Kim RS, et al. Intestinal brush-border Na+/H+ exchanger-3 drives H+-coupled iron absorption in the mouse. Am J Physiol Gastrointest Liver Physiol. 2016; 311:G423–G430.
-
(2016)
Am J Physiol Gastrointest Liver Physiol.
, vol.311
, pp. G423-G430
-
-
Shawki, A.1
Engevik, M.A.2
Kim, R.S.3
-
13
-
-
0014265208
-
Absorption of hemoglobin iron: The role of a heme-splitting substance in the intestinal mucosa
-
Weintraub LR, Weinstein MB, Huser HJ, et al. Absorption of hemoglobin iron: The role of a heme-splitting substance in the intestinal mucosa. J Clin Invest. 1968; 47:531–539.
-
(1968)
J Clin Invest.
, vol.47
, pp. 531-539
-
-
Weintraub, L.R.1
Weinstein, M.B.2
Huser, H.J.3
-
14
-
-
84863229838
-
Absorption of iron from ferritin is independent of heme iron and ferrous salts in women and rat intestinal segments
-
Theil EC, Chen H, Miranda C, et al. Absorption of iron from ferritin is independent of heme iron and ferrous salts in women and rat intestinal segments. J Nutr. 2012; 142:478–483.
-
(2012)
J Nutr.
, vol.142
, pp. 478-483
-
-
Theil, E.C.1
Chen, H.2
Miranda, C.3
-
15
-
-
84945962756
-
The importance of eukaryotic ferritins in iron handling and cytoprotection
-
Arosio P, Carmona F, Gozzelino R, Maccarinelli F, Poli M. The importance of eukaryotic ferritins in iron handling and cytoprotection. Biochem J. 2015; 472:1–15.
-
(2015)
Biochem J.
, vol.472
, pp. 1-15
-
-
Arosio, P.1
Carmona, F.2
Gozzelino, R.3
Maccarinelli, F.4
Poli, M.5
-
16
-
-
77956327702
-
Intestinal ferritin H is required for an accurate control of iron absorption
-
Vanoaica L, Darshan D, Richman L, Schümann K, Kühn LC. Intestinal ferritin H is required for an accurate control of iron absorption. Cell Metab. 2010; 12:273–282.
-
(2010)
Cell Metab.
, vol.12
, pp. 273-282
-
-
Vanoaica, L.1
Darshan, D.2
Richman, L.3
Schümann, K.4
Kühn, L.C.5
-
17
-
-
0034677467
-
Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter
-
Donovan A, Brownlie A, Zhou Y, et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature. 2000; 403:776–781.
-
(2000)
Nature.
, vol.403
, pp. 776-781
-
-
Donovan, A.1
Brownlie, A.2
Zhou, Y.3
-
18
-
-
0034733635
-
A novel mammalian iron-regulated protein involved in intracellular iron metabolism
-
Abboud S, Haile DJ. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem. 2000; 275:19906–19912.
-
(2000)
J Biol Chem.
, vol.275
, pp. 19906-19912
-
-
Abboud, S.1
Haile, D.J.2
-
19
-
-
0033861745
-
A novel duodenal ironregulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation
-
McKie AT, Marciani P, Rolfs A, et al. A novel duodenal ironregulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell. 2000; 5:299–309.
-
(2000)
Mol Cell.
, vol.5
, pp. 299-309
-
-
McKie, A.T.1
Marciani, P.2
Rolfs, A.3
-
21
-
-
0032909207
-
Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse
-
Vulpe CD, Kuo YM, Murphy TL, et al. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet. 1999; 21:195–199.
-
(1999)
Nat Genet.
, vol.21
, pp. 195-199
-
-
Vulpe, C.D.1
Kuo, Y.M.2
Murphy, T.L.3
-
22
-
-
0032875387
-
Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux
-
Harris ZL, Durley AP, Man TK, Gitlin JD. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc Natl Acad Sci USA. 1999; 96:10812–10817.
-
(1999)
Proc Natl Acad Sci USA.
, vol.96
, pp. 10812-10817
-
-
Harris, Z.L.1
Durley, A.P.2
Man, T.K.3
Gitlin, J.D.4
-
23
-
-
33645070287
-
Unexpected role of ceruloplasmin in intestinal iron absorption
-
Cherukuri S, Potla R, Sarkar J, Nurko S, Harris ZL, Fox PL. Unexpected role of ceruloplasmin in intestinal iron absorption. Cell Metab. 2005; 2:309–319.
-
(2005)
Cell Metab.
, vol.2
, pp. 309-319
-
-
Cherukuri, S.1
Potla, R.2
Sarkar, J.3
Nurko, S.4
Harris, Z.L.5
Fox, P.L.6
-
24
-
-
84923293373
-
The second transferrin receptor regulates red blood cell production in mice
-
Nai A, Lidonnici MR, Rausa M, et al. The second transferrin receptor regulates red blood cell production in mice. Blood. 2015; 125:1170–1179.
-
(2015)
Blood.
, vol.125
, pp. 1170-1179
-
-
Nai, A.1
Lidonnici, M.R.2
Rausa, M.3
-
26
-
-
84937525787
-
SLC39A14 Is Required for the development of hepatocellular iron overload in murine models of hereditary hemochromatosis
-
Jenkitkasemwong S, Wang CY, Coffey R, et al. SLC39A14 Is Required for the development of hepatocellular iron overload in murine models of hereditary hemochromatosis. Cell Metab. 2015; 22:138–150.
-
(2015)
Cell Metab.
, vol.22
, pp. 138-150
-
-
Jenkitkasemwong, S.1
Wang, C.Y.2
Coffey, R.3
-
27
-
-
77956605615
-
Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway
-
Cohen LA, Gutierrez L, Weiss A, et al. Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway. Blood. 2010; 116:1574–1584.
-
(2010)
Blood.
, vol.116
, pp. 1574-1584
-
-
Cohen, L.A.1
Gutierrez, L.2
Weiss, A.3
-
29
-
-
77955886660
-
Iron traffics in circulation bound to a siderocalin (Ngal)-catechol complex
-
Bao G, Clifton M, Hoette TM, et al. Iron traffics in circulation bound to a siderocalin (Ngal)-catechol complex. Nat Chem Biol. 2010; 6:602–609.
-
(2010)
Nat Chem Biol.
, vol.6
, pp. 602-609
-
-
Bao, G.1
Clifton, M.2
Hoette, T.M.3
-
30
-
-
45849123222
-
A cytosolic iron chaperone that delivers iron to ferritin
-
Shi H, Bencze KZ, Stemmler TL, Philpott CC. A cytosolic iron chaperone that delivers iron to ferritin. Science. 2008; 320:1207–1210.
-
(2008)
Science.
, vol.320
, pp. 1207-1210
-
-
Shi, H.1
Bencze, K.Z.2
Stemmler, T.L.3
Philpott, C.C.4
-
31
-
-
0030846021
-
Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin
-
Babcock M, de Silva D, Oaks R, et al. Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science. 1997; 276:1709–1712.
-
(1997)
Science.
, vol.276
, pp. 1709-1712
-
-
Babcock, M.1
de Silva, D.2
Oaks, R.3
-
32
-
-
33644748145
-
Mitoferrin is essential for erythroid iron assimilation
-
Shaw GC, Cope JJ, Li L, et al. Mitoferrin is essential for erythroid iron assimilation. Nature. 2006; 440:96–100.
-
(2006)
Nature.
, vol.440
, pp. 96-100
-
-
Shaw, G.C.1
Cope, J.J.2
Li, L.3
-
33
-
-
84870514416
-
The mitochondrial heme exporter FLVCR1b mediates erythroid differentiation
-
Chiabrando D, Marro S, Mercurio S, et al. The mitochondrial heme exporter FLVCR1b mediates erythroid differentiation. J Clin Invest. 2012; 122:4569–4579.
-
(2012)
J Clin Invest.
, vol.122
, pp. 4569-4579
-
-
Chiabrando, D.1
Marro, S.2
Mercurio, S.3
-
34
-
-
84899746695
-
Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy
-
Mancias JD, Wang X, Gygi SP, Harper JW, Kimmelman AC. Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature. 2014; 509:105–109.
-
(2014)
Nature.
, vol.509
, pp. 105-109
-
-
Mancias, J.D.1
Wang, X.2
Gygi, S.P.3
Harper, J.W.4
Kimmelman, A.C.5
-
35
-
-
84946615455
-
Ferritinophagy via NCOA4 is required for erythropoiesis and is regulated by iron dependent HERC2-mediated proteolysis
-
Mancias JD, Pontano Vaites L, Nissim S, et al. Ferritinophagy via NCOA4 is required for erythropoiesis and is regulated by iron dependent HERC2-mediated proteolysis. Elife. 2015; 4:e10308.
-
(2015)
Elife.
, vol.4
-
-
Mancias, J.D.1
Pontano Vaites, L.2
Nissim, S.3
-
36
-
-
38949097546
-
A heme export protein is required for red blood cell differentiation and iron homeostasis
-
Keel SB, Doty RT, Yang Z, et al. A heme export protein is required for red blood cell differentiation and iron homeostasis. Science. 2008; 319:825–828.
-
(2008)
Science.
, vol.319
, pp. 825-828
-
-
Keel, S.B.1
Doty, R.T.2
Yang, Z.3
-
37
-
-
50949102412
-
Systemic iron homeostasis and the iron-responsive element/ironregulatory protein (IRE/IRP) regulatory network
-
Muckenthaler MU, Galy B, Hentze MW. Systemic iron homeostasis and the iron-responsive element/ironregulatory protein (IRE/IRP) regulatory network. Annu Rev Nutr. 2008; 28:197–213.
-
(2008)
Annu Rev Nutr.
, vol.28
, pp. 197-213
-
-
Muckenthaler, M.U.1
Galy, B.2
Hentze, M.W.3
-
38
-
-
70350613915
-
Control of iron homeostasis by an iron-regulated ubiquitin ligase
-
Vashisht AA, Zumbrennen KB, Huang X, et al. Control of iron homeostasis by an iron-regulated ubiquitin ligase. Science. 2009; 326:718–721.
-
(2009)
Science.
, vol.326
, pp. 718-721
-
-
Vashisht, A.A.1
Zumbrennen, K.B.2
Huang, X.3
-
39
-
-
70350576223
-
An E3 ligase possessing an iron-responsive hemerythrin domain is a regulator of iron homeostasis
-
Salahudeen AA, Thompson JW, Ruiz JC, et al. An E3 ligase possessing an iron-responsive hemerythrin domain is a regulator of iron homeostasis. Science. 2009; 326:722–726.
-
(2009)
Science.
, vol.326
, pp. 722-726
-
-
Salahudeen, A.A.1
Thompson, J.W.2
Ruiz, J.C.3
-
40
-
-
38349111676
-
Role of the hypoxia inducible factors HIF in iron metabolism
-
Peyssonnaux C, Nizet V, Johnson RS. Role of the hypoxia inducible factors HIF in iron metabolism. Cell Cycle. 2008; 7:28–32.
-
(2008)
Cell Cycle.
, vol.7
, pp. 28-32
-
-
Peyssonnaux, C.1
Nizet, V.2
Johnson, R.S.3
-
41
-
-
33847796951
-
Acute postnatal ablation of Hif-2α results in anemia
-
Gruber M, Hu CJ, Johnson RS, Brown EJ, Keith B, Simon MC. Acute postnatal ablation of Hif-2α results in anemia. Proc Natl Acad Sci USA. 2007; 104:2301–2306.
-
(2007)
Proc Natl Acad Sci USA.
, vol.104
, pp. 2301-2306
-
-
Gruber, M.1
Hu, C.J.2
Johnson, R.S.3
Brown, E.J.4
Keith, B.5
Simon, M.C.6
-
42
-
-
58749094789
-
Intestinal hypoxia-inducible transcription factors are essential for iron absorption following iron deficiency
-
Shah YM, Matsubara T, Ito S, Yim SH, Gonzalez FJ. Intestinal hypoxia-inducible transcription factors are essential for iron absorption following iron deficiency. Cell Metab. 2009; 9:152–164.
-
(2009)
Cell Metab.
, vol.9
, pp. 152-164
-
-
Shah, Y.M.1
Matsubara, T.2
Ito, S.3
Yim, S.H.4
Gonzalez, F.J.5
-
43
-
-
79958146087
-
Hypoxia-inducible factor-2α mediates the adaptive increase of intestinal ferroportin during iron deficiency in mice
-
Taylor M, Qu A, Anderson ER, et al. Hypoxia-inducible factor-2α mediates the adaptive increase of intestinal ferroportin during iron deficiency in mice. Gastroenterology. 2011; 140:2044–2055.
-
(2011)
Gastroenterology.
, vol.140
, pp. 2044-2055
-
-
Taylor, M.1
Qu, A.2
Anderson, E.R.3
-
44
-
-
84873361483
-
The IRP1-HIF-2α axis coordinates iron and oxygen sensing with erythropoiesis and iron absorption
-
Anderson SA, Nizzi CP, Chang YI, et al. The IRP1-HIF-2α axis coordinates iron and oxygen sensing with erythropoiesis and iron absorption. Cell Metab. 2013; 17:282–290.
-
(2013)
Cell Metab.
, vol.17
, pp. 282-290
-
-
Anderson, S.A.1
Nizzi, C.P.2
Chang, Y.I.3
-
45
-
-
10844258104
-
Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization
-
Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004; 306:2090–2093.
-
(2004)
Science.
, vol.306
, pp. 2090-2093
-
-
Nemeth, E.1
Tuttle, M.S.2
Powelson, J.3
-
46
-
-
84902194073
-
Targeted disruption of hepcidin in the liver recapitulates the hemochromatotic phenotype
-
Zumerle S, Mathieu JR, Delga S, et al. Targeted disruption of hepcidin in the liver recapitulates the hemochromatotic phenotype. Blood. 2014; 123:3646–3650.
-
(2014)
Blood.
, vol.123
, pp. 3646-3650
-
-
Zumerle, S.1
Mathieu, J.R.2
Delga, S.3
-
47
-
-
84958780878
-
Hepcidin regulation in the anemia of inflammation
-
Wang CY, Babitt JL. Hepcidin regulation in the anemia of inflammation. Curr Opin Hematol. 2016; 23:189–197.
-
(2016)
Curr Opin Hematol.
, vol.23
, pp. 189-197
-
-
Wang, C.Y.1
Babitt, J.L.2
-
48
-
-
85018018795
-
-
de Benoist B, McLean E, Egli I, Cogswell M. eds., World prevalence of anaemia 1993-2005, Geneva, World Health Organization
-
de Benoist B, McLean E, Egli I, Cogswell M. eds. World prevalence of anaemia 1993-2005. WHO Global Database on Anaemia. Geneva, World Health Organization, 2008. http://www.who.int/nutrition/publications/micronutrients/anaemia_iron_deficiency/9789241596657/en/
-
(2008)
-
-
-
50
-
-
33646345152
-
KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease
-
National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis. 2006; 47:S1–145.
-
(2006)
Am J Kidney Dis.
, vol.47
, pp. S1-145
-
-
-
51
-
-
84896733066
-
The iron cycle in chronic kidney disease (CKD): From genetics and experimental models to CKD patients
-
Zumbrennen-Bullough K, Babitt JL. The iron cycle in chronic kidney disease (CKD): From genetics and experimental models to CKD patients. Nephrol Dial Transplant. 2014; 29:263–273.
-
(2014)
Nephrol Dial Transplant.
, vol.29
, pp. 263-273
-
-
Zumbrennen-Bullough, K.1
Babitt, J.L.2
-
52
-
-
12844260664
-
Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload
-
Mims MP, Guan Y, Pospisilova D, et al. Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload. Blood. 2005; 105:1337–1342.
-
(2005)
Blood.
, vol.105
, pp. 1337-1342
-
-
Mims, M.P.1
Guan, Y.2
Pospisilova, D.3
-
53
-
-
0034672337
-
Molecular characterization of a case of atransferrinemia
-
Beutler E, Gelbart T, Lee P, Trevino R, Fernandez MA, Fairbanks VF. Molecular characterization of a case of atransferrinemia. Blood. 2000; 96:4071–4074.
-
(2000)
Blood.
, vol.96
, pp. 4071-4074
-
-
Beutler, E.1
Gelbart, T.2
Lee, P.3
Trevino, R.4
Fernandez, M.A.5
Fairbanks, V.F.6
-
54
-
-
0028903259
-
Aceruloplasminemia: Molecular characterization of this disorder of iron metabolism
-
Harris ZL, Takahashi Y, Miyajima H, Serizawa M, MacGillivray RT, Gitlin JD. Aceruloplasminemia: Molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci USA. 1995; 92:2539–2543.
-
(1995)
Proc Natl Acad Sci USA.
, vol.92
, pp. 2539-2543
-
-
Harris, Z.L.1
Takahashi, Y.2
Miyajima, H.3
Serizawa, M.4
MacGillivray, R.T.5
Gitlin, J.D.6
-
55
-
-
42649118442
-
Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)
-
Finberg KE, Heeney MM, Campagna DR, et al. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat Genet. 2008; 40:569–571.
-
(2008)
Nat Genet.
, vol.40
, pp. 569-571
-
-
Finberg, K.E.1
Heeney, M.M.2
Campagna, D.R.3
-
56
-
-
44449177930
-
The serine protease TMPRSS6 is required to sense iron deficiency
-
Du X, She E, Gelbart T, et al. The serine protease TMPRSS6 is required to sense iron deficiency. Science. 2008; 320:1088–1092.
-
(2008)
Science.
, vol.320
, pp. 1088-1092
-
-
Du, X.1
She, E.2
Gelbart, T.3
-
57
-
-
84952802841
-
Iron and the liver
-
Pietrangelo A. Iron and the liver. Liver Int. 2016; 36:116–123.
-
(2016)
Liver Int.
, vol.36
, pp. 116-123
-
-
Pietrangelo, A.1
-
58
-
-
84956923279
-
Ineffective erythropoiesis and regulation of iron status in iron loading anaemias
-
Camaschella C, Nai A. Ineffective erythropoiesis and regulation of iron status in iron loading anaemias. Br J Haematol. 2016; 172:512–523.
-
(2016)
Br J Haematol.
, vol.172
, pp. 512-523
-
-
Camaschella, C.1
Nai, A.2
-
59
-
-
20244388240
-
Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis
-
Roetto A, Papanikolaou G, Politou M, et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet. 2003; 33:21–22.
-
(2003)
Nat Genet.
, vol.33
, pp. 21-22
-
-
Roetto, A.1
Papanikolaou, G.2
Politou, M.3
-
60
-
-
9344224529
-
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
-
Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996; 13:399–408.
-
(1996)
Nat Genet.
, vol.13
, pp. 399-408
-
-
Feder, J.N.1
Gnirke, A.2
Thomas, W.3
-
61
-
-
0034022636
-
The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22
-
Camaschella C, Roetto A, Calì A, et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet. 2000; 25:14–15.
-
(2000)
Nat Genet.
, vol.25
, pp. 14-15
-
-
Camaschella, C.1
Roetto, A.2
Calì, A.3
-
62
-
-
9144252017
-
Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis
-
Papanikolaou G, Samuels ME, Ludwig EH, et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet. 2004; 36:77–82.
-
(2004)
Nat Genet.
, vol.36
, pp. 77-82
-
-
Papanikolaou, G.1
Samuels, M.E.2
Ludwig, E.H.3
-
63
-
-
23044508432
-
Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin
-
Drakesmith H, Schimanski LM, Ormerod E, et al. Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin. Blood. 2005; 106:1092–1097.
-
(2005)
Blood.
, vol.106
, pp. 1092-1097
-
-
Drakesmith, H.1
Schimanski, L.M.2
Ormerod, E.3
-
64
-
-
17944380796
-
Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene
-
Montosi G, Donovan A, Totaro A, et al. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest. 2001; 108:619–623.
-
(2001)
J Clin Invest.
, vol.108
, pp. 619-623
-
-
Montosi, G.1
Donovan, A.2
Totaro, A.3
-
65
-
-
84903578007
-
Identification of erythroferrone as an erythroid regulator of iron metabolism
-
Kautz L, Jung G, Valore EV, Rivella S, Nemeth E, Ganz T. Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat Genet. 2014; 46:678–684.
-
(2014)
Nat Genet.
, vol.46
, pp. 678-684
-
-
Kautz, L.1
Jung, G.2
Valore, E.V.3
Rivella, S.4
Nemeth, E.5
Ganz, T.6
-
66
-
-
84943786773
-
Understanding the recent increase in ferritin levels in United States dialysis patients: Potential impact of changes in intravenous iron and erythropoiesis-stimulating agent dosing
-
Karaboyas A, Zee J, Morgenstern H, et al. Understanding the recent increase in ferritin levels in United States dialysis patients: Potential impact of changes in intravenous iron and erythropoiesis-stimulating agent dosing. Clin J Am Soc Nephrol. 2015; 10:1814–1821.
-
(2015)
Clin J Am Soc Nephrol.
, vol.10
, pp. 1814-1821
-
-
Karaboyas, A.1
Zee, J.2
Morgenstern, H.3
-
67
-
-
33744919003
-
High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis
-
McClain DA, Abraham D, Rogers J, et al. High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis. Diabetologia. 2006; 49:1661–1669.
-
(2006)
Diabetologia.
, vol.49
, pp. 1661-1669
-
-
McClain, D.A.1
Abraham, D.2
Rogers, J.3
-
68
-
-
68949208818
-
Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America
-
Vogiatzi MG, Macklin EA, Trachtenberg FL, et al. Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America. Br J Haematol. 2009; 146:546–556.
-
(2009)
Br J Haematol.
, vol.146
, pp. 546-556
-
-
Vogiatzi, M.G.1
Macklin, E.A.2
Trachtenberg, F.L.3
-
69
-
-
0033364044
-
Diabetes and serum ferritin concentration among U.S. adults
-
Ford ES, Cogswell ME. Diabetes and serum ferritin concentration among U.S. adults. Diabetes Care. 1999; 22:1978–1983.
-
(1999)
Diabetes Care.
, vol.22
, pp. 1978-1983
-
-
Ford, E.S.1
Cogswell, M.E.2
-
70
-
-
14744290384
-
Dietary iron intake and blood donations in relation to risk of type 2 diabetes in men: A prospective cohort study
-
Jiang R, Ma J, Ascherio A, Stampfer MJ, Willett WC, Hu FB. Dietary iron intake and blood donations in relation to risk of type 2 diabetes in men: A prospective cohort study. Am J Clin Nutr. 2004; 79:70–75.
-
(2004)
Am J Clin Nutr.
, vol.79
, pp. 70-75
-
-
Jiang, R.1
Ma, J.2
Ascherio, A.3
Stampfer, M.J.4
Willett, W.C.5
Hu, F.B.6
-
71
-
-
4444230462
-
A prospective study of red meat consumption and type 2 diabetes in middle-aged and elderly women: The women's health study
-
Song Y, Manson JE, Buring JE, Liu S. A prospective study of red meat consumption and type 2 diabetes in middle-aged and elderly women: The women's health study. Diabetes Care. 2004; 27:2108–2115.
-
(2004)
Diabetes Care.
, vol.27
, pp. 2108-2115
-
-
Song, Y.1
Manson, J.E.2
Buring, J.E.3
Liu, S.4
-
72
-
-
1442314640
-
Body iron stores in relation to risk of type 2 diabetes in apparently healthy women
-
Jiang R, Manson JE, Meigs JB, Ma J, Rifai N, Hu FB. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA. 2004; 291:711–717.
-
(2004)
JAMA.
, vol.291
, pp. 711-717
-
-
Jiang, R.1
Manson, J.E.2
Meigs, J.B.3
Ma, J.4
Rifai, N.5
Hu, F.B.6
-
73
-
-
0015295917
-
Observations on the pathogenesis, complications and treatment of diabetes in 115 cases of haemochromatosis
-
Dymock IW, Cassar J, Pyke DA, Oakley WG, Williams R. Observations on the pathogenesis, complications and treatment of diabetes in 115 cases of haemochromatosis. Am J Med. 1972; 52:203–210.
-
(1972)
Am J Med.
, vol.52
, pp. 203-210
-
-
Dymock, I.W.1
Cassar, J.2
Pyke, D.A.3
Oakley, W.G.4
Williams, R.5
-
74
-
-
12544253460
-
Glucose metabolism disorders improvement in patients with thalassaemia major after 24-36 months of intensive chelation therapy
-
Platis O, Anagnostopoulos G, Farmaki K, Posantzis M, Gotsis E, Tolis G. Glucose metabolism disorders improvement in patients with thalassaemia major after 24-36 months of intensive chelation therapy. Pediatr Endocrinol Rev. 2004; 2:279–281.
-
(2004)
Pediatr Endocrinol Rev.
, vol.2
, pp. 279-281
-
-
Platis, O.1
Anagnostopoulos, G.2
Farmaki, K.3
Posantzis, M.4
Gotsis, E.5
Tolis, G.6
-
75
-
-
0036231727
-
Blood letting in high-ferritin type 2 diabetes: Effects on insulin sensitivity and beta-cell function
-
Fernández-Real JM, Peñarroja G, Castro A, García-Bragado F, Hernández-Aguado I, Ricart W. Blood letting in high-ferritin type 2 diabetes: Effects on insulin sensitivity and beta-cell function. Diabetes. 2002; 51:1000–1004.
-
(2002)
Diabetes.
, vol.51
, pp. 1000-1004
-
-
Fernández-Real, J.M.1
Peñarroja, G.2
Castro, A.3
García-Bragado, F.4
Hernández-Aguado, I.5
Ricart, W.6
-
77
-
-
9244230038
-
Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis
-
Cooksey RC, Jouihan HA, Ajioka RS, et al. Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis. Endocrinology. 2004; 145:5305–5312.
-
(2004)
Endocrinology.
, vol.145
, pp. 5305-5312
-
-
Cooksey, R.C.1
Jouihan, H.A.2
Ajioka, R.S.3
-
78
-
-
84867167258
-
Adipocyte iron regulates adiponectin and insulin sensitivity
-
Gabrielsen JS, Gao Y, Simcox JA, et al. Adipocyte iron regulates adiponectin and insulin sensitivity. J Clin Invest. 2012; 122:3529–3540.
-
(2012)
J Clin Invest.
, vol.122
, pp. 3529-3540
-
-
Gabrielsen, J.S.1
Gao, Y.2
Simcox, J.A.3
-
79
-
-
84880327550
-
American heart association committee on heart failure and transplantation of the council on clinical cardiology and council on cardiovascular radiology and imaging. Cardiovascular function and treatment in β-thalassemia major: A consensus statement from the American Heart Association
-
Pennell DJ, Udelson JE, Arai AE, et al. American heart association committee on heart failure and transplantation of the council on clinical cardiology and council on cardiovascular radiology and imaging. Cardiovascular function and treatment in β-thalassemia major: A consensus statement from the American Heart Association. Circulation. 2013; 128:281–308.
-
(2013)
Circulation.
, vol.128
, pp. 281-308
-
-
Pennell, D.J.1
Udelson, J.E.2
Arai, A.E.3
-
80
-
-
78149284772
-
Iron-overload cardiomyopathy: Pathophysiology, diagnosis, and treatment
-
Murphy CJ, Oudit GY. Iron-overload cardiomyopathy: Pathophysiology, diagnosis, and treatment. J Card Fail. 2010; 16:888–900.
-
(2010)
J Card Fail.
, vol.16
, pp. 888-900
-
-
Murphy, C.J.1
Oudit, G.Y.2
-
81
-
-
84875474830
-
Iron deficiency in chronic heart failure: An international pooled analysis
-
Klip IT, Comin-Colet J, Voors AA, et al. Iron deficiency in chronic heart failure: An international pooled analysis. Am Heart J. 2013; 165:575–582. e573.
-
(2013)
Am Heart J.
, vol.165
, pp. 575-582
-
-
Klip, I.T.1
Comin-Colet, J.2
Voors, A.A.3
-
82
-
-
84884553015
-
Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status
-
Comin-Colet J, Enjuanes C, Gonzalez G, et al. Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status. Eur J Heart Fail. 2013; 15:1164–1172.
-
(2013)
Eur J Heart Fail.
, vol.15
, pp. 1164-1172
-
-
Comin-Colet, J.1
Enjuanes, C.2
Gonzalez, G.3
-
83
-
-
72449156527
-
Ferric carboxymaltose in patients with heart failure and iron deficiency
-
Anker SD, Comin Colet J, Filippatos G, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009; 361:2436–2448.
-
(2009)
N Engl J Med.
, vol.361
, pp. 2436-2448
-
-
Anker, S.D.1
Comin Colet, J.2
Filippatos, G.3
-
84
-
-
84925275800
-
Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency
-
Ponikowski P, van Veldhuisen DJ, Comin-Colet J, et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. Eur Heart J. 2015; 36:657–668.
-
(2015)
Eur Heart J.
, vol.36
, pp. 657-668
-
-
Ponikowski, P.1
van Veldhuisen, D.J.2
Comin-Colet, J.3
-
85
-
-
0019434645
-
Iron and the sex difference in heart disease risk
-
Sullivan JL. Iron and the sex difference in heart disease risk. Lancet. 1981; 1:1293–1294.
-
(1981)
Lancet.
, vol.1
, pp. 1293-1294
-
-
Sullivan, J.L.1
-
86
-
-
0028353561
-
Dietary iron intake and risk of coronary disease among men
-
Ascherio A, Willett WC, Rimm EB, Giovannucci EL, Stampfer MJ. Dietary iron intake and risk of coronary disease among men. Circulation. 1994; 89:969–974.
-
(1994)
Circulation.
, vol.89
, pp. 969-974
-
-
Ascherio, A.1
Willett, W.C.2
Rimm, E.B.3
Giovannucci, E.L.4
Stampfer, M.J.5
-
87
-
-
13544261509
-
Dietary haem iron and coronary heart disease in women
-
van der A DL, Peeters PH, Grobbee DE, Marx JJ, van der Schouw YT. Dietary haem iron and coronary heart disease in women. Eur Heart J. 2005; 26:257–262.
-
(2005)
Eur Heart J.
, vol.26
, pp. 257-262
-
-
Vander, D.L.1
Peeters, P.H.2
Grobbee, D.E.3
Marx, J.J.4
van der Schouw, Y.T.5
-
88
-
-
0030778795
-
Body iron stores and the risk of carotid atherosclerosis: Prospective results from the Bruneck study
-
Kiechl S, Willeit J, Egger G, Poewe W, Oberhollenzer F. Body iron stores and the risk of carotid atherosclerosis: Prospective results from the Bruneck study. Circulation. 1997; 96:3300–3307.
-
(1997)
Circulation.
, vol.96
, pp. 3300-3307
-
-
Kiechl, S.1
Willeit, J.2
Egger, G.3
Poewe, W.4
Oberhollenzer, F.5
-
89
-
-
0033596677
-
Coronary heart disease and iron status: Meta-analyses of prospective studies
-
Danesh J, Appleby P. Coronary heart disease and iron status: Meta-analyses of prospective studies. Circulation. 1999; 99:852–854.
-
(1999)
Circulation.
, vol.99
, pp. 852-854
-
-
Danesh, J.1
Appleby, P.2
-
90
-
-
84923950749
-
Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD
-
Kuo KL, Hung SC, Lee TS, Tarng DC. Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD. J Am Soc Nephrol. 2014; 25:2596–2606.
-
(2014)
J Am Soc Nephrol.
, vol.25
, pp. 2596-2606
-
-
Kuo, K.L.1
Hung, S.C.2
Lee, T.S.3
Tarng, D.C.4
-
91
-
-
67349180293
-
Iron in arterial plaque: Modifiable risk factor for atherosclerosis
-
Sullivan JL. Iron in arterial plaque: Modifiable risk factor for atherosclerosis. Biochim Biophys Acta. 2009; 1790:718–723.
-
(2009)
Biochim Biophys Acta.
, vol.1790
, pp. 718-723
-
-
Sullivan, J.L.1
-
92
-
-
84890237720
-
Testing the iron hypothesis in a mouse model of atherosclerosis
-
Kautz L, Gabayan V, Wang X, et al. Testing the iron hypothesis in a mouse model of atherosclerosis. Cell Rep. 2013; 5:1436–1442.
-
(2013)
Cell Rep.
, vol.5
, pp. 1436-1442
-
-
Kautz, L.1
Gabayan, V.2
Wang, X.3
-
93
-
-
84920107364
-
Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality
-
Bailie GR, Larkina M, Goodkin DA, et al. Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality. Kidney Int. 2015; 87:162–168.
-
(2015)
Kidney Int.
, vol.87
, pp. 162-168
-
-
Bailie, G.R.1
Larkina, M.2
Goodkin, D.A.3
-
94
-
-
84891434596
-
Intravenous iron supplementation practices and short-term risk of cardiovascular events in hemodialysis patients
-
Kshirsagar AV, Freburger JK, Ellis AR, Wang L, Winkelmayer WC, Brookhart MA. Intravenous iron supplementation practices and short-term risk of cardiovascular events in hemodialysis patients. PLoS One. 2013; 8:e78930
-
(2013)
PLoS One.
, vol.8
-
-
Kshirsagar, A.V.1
Freburger, J.K.2
Ellis, A.R.3
Wang, L.4
Winkelmayer, W.C.5
Brookhart, M.A.6
-
95
-
-
84926442768
-
Developing evidence to inform decisions about effectiveness (DEcIDE) network patient outcomes in end stage renal disease study investigators. Intravenous iron exposure and mortality in patients on hemodialysis
-
Miskulin DC, Tangri N, Bandeen-Roche K, et al. Developing evidence to inform decisions about effectiveness (DEcIDE) network patient outcomes in end stage renal disease study investigators. Intravenous iron exposure and mortality in patients on hemodialysis. Clin J Am Soc Nephrol. 2014; 9:1930–1939.
-
(2014)
Clin J Am Soc Nephrol.
, vol.9
, pp. 1930-1939
-
-
Miskulin, D.C.1
Tangri, N.2
Bandeen-Roche, K.3
-
97
-
-
0038670759
-
Iron deficiency alters brain development and functioning
-
Beard J. Iron deficiency alters brain development and functioning. J Nutr. 2003; 133:1468S–1472S.
-
(2003)
J Nutr.
, vol.133
, pp. 1468S-1472S
-
-
Beard, J.1
-
98
-
-
58149396754
-
Brain iron deficiency and excess; cognitive impairment and neurodegeneration with involvement of striatum and hippocampus
-
Youdim MB. Brain iron deficiency and excess; cognitive impairment and neurodegeneration with involvement of striatum and hippocampus. Neurotox Res. 2008; 14:45–56.
-
(2008)
Neurotox Res.
, vol.14
, pp. 45-56
-
-
Youdim, M.B.1
-
99
-
-
84894475785
-
Brain iron homeostasis: From molecular mechanisms to clinical significance and therapeutic opportunities
-
Singh N, Haldar S, Tripathi AK, et al. Brain iron homeostasis: From molecular mechanisms to clinical significance and therapeutic opportunities. Antioxid Redox Signal. 2014; 20:1324–1363.
-
(2014)
Antioxid Redox Signal.
, vol.20
, pp. 1324-1363
-
-
Singh, N.1
Haldar, S.2
Tripathi, A.K.3
-
101
-
-
84880805523
-
Iron metabolism in the CNS: Implications for neurodegenerative diseases
-
Rouault TA. Iron metabolism in the CNS: Implications for neurodegenerative diseases. Nat Rev Neurosci. 2013; 14:551–564.
-
(2013)
Nat Rev Neurosci.
, vol.14
, pp. 551-564
-
-
Rouault, T.A.1
-
102
-
-
84979698328
-
Loss of Frataxin induces iron toxicity, sphingolipid synthesis, and Pdk1/Mef2 activation, leading to neurodegeneration
-
Chen K, Lin G, Haelterman NA, et al. Loss of Frataxin induces iron toxicity, sphingolipid synthesis, and Pdk1/Mef2 activation, leading to neurodegeneration. Elife. 2016; 5:e20732.
-
(2016)
Elife.
, vol.5
-
-
Chen, K.1
Lin, G.2
Haelterman, N.A.3
-
103
-
-
0347928847
-
An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript
-
Rogers JT, Randall JD, Cahill CM, et al. An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript. J Biol Chem. 2002; 277:45518–45528.
-
(2002)
J Biol Chem.
, vol.277
, pp. 45518-45528
-
-
Rogers, J.T.1
Randall, J.D.2
Cahill, C.M.3
-
104
-
-
33847320669
-
The 5'-untranslated region of Parkinson's disease alpha-synuclein messengerRNA contains a predicted iron responsive element
-
Friedlich AL, Tanzi RE, Rogers JT. The 5'-untranslated region of Parkinson's disease alpha-synuclein messengerRNA contains a predicted iron responsive element. Mol Psychiatry. 2007; 12:222–223.
-
(2007)
Mol Psychiatry.
, vol.12
, pp. 222-223
-
-
Friedlich, A.L.1
Tanzi, R.E.2
Rogers, J.T.3
-
105
-
-
77956647381
-
Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease
-
Duce JA, Tsatsanis A, Cater MA, et al. Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell. 2010; 142:857–867.
-
(2010)
Cell.
, vol.142
, pp. 857-867
-
-
Duce, J.A.1
Tsatsanis, A.2
Cater, M.A.3
-
106
-
-
84914693430
-
β-Amyloid precursor protein does not possess ferroxidase activity but does stabilize the cell surface ferrous iron exporter ferroportin
-
Wong BX, Tsatsanis A, Lim LQ, Adlard PA, Bush AI, Duce JA. β-Amyloid precursor protein does not possess ferroxidase activity but does stabilize the cell surface ferrous iron exporter ferroportin. PLoS One. 2014; 9:e114174
-
(2014)
PLoS One.
, vol.9
-
-
Wong, B.X.1
Tsatsanis, A.2
Lim, L.Q.3
Adlard, P.A.4
Bush, A.I.5
Duce, J.A.6
-
107
-
-
57449092273
-
Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease
-
Salazar J, Mena N, Hunot S, et al. Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease. Proc Natl Acad Sci USA. 2008; 105:18578–18583.
-
(2008)
Proc Natl Acad Sci USA.
, vol.105
, pp. 18578-18583
-
-
Salazar, J.1
Mena, N.2
Hunot, S.3
-
108
-
-
78650695967
-
Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease
-
Jin L, Wang J, Zhao L, et al. Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease. Brain. 2011; 134:50–58.
-
(2011)
Brain.
, vol.134
, pp. 50-58
-
-
Jin, L.1
Wang, J.2
Zhao, L.3
-
109
-
-
0035127525
-
Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease
-
Fracanzani AL, Conte D, Fraquelli M, et al. Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease. Hepatology. 2001; 33:647–651.
-
(2001)
Hepatology.
, vol.33
, pp. 647-651
-
-
Fracanzani, A.L.1
Conte, D.2
Fraquelli, M.3
-
110
-
-
77950620367
-
HFE C282Y homozygotes are at increased risk of breast and colorectal cancer
-
Osborne NJ, Gurrin LC, Allen KJ, et al. HFE C282Y homozygotes are at increased risk of breast and colorectal cancer. Hepatology. 2010; 51:1311–1318.
-
(2010)
Hepatology.
, vol.51
, pp. 1311-1318
-
-
Osborne, N.J.1
Gurrin, L.C.2
Allen, K.J.3
-
111
-
-
9144224804
-
Hepatocellular carcinoma in the thalassaemia syndromes
-
Borgna-Pignatti C, Vergine G, Lombardo T, et al. Hepatocellular carcinoma in the thalassaemia syndromes. Br J Haematol. 2004; 124:114–117.
-
(2004)
Br J Haematol.
, vol.124
, pp. 114-117
-
-
Borgna-Pignatti, C.1
Vergine, G.2
Lombardo, T.3
-
112
-
-
84959124605
-
Iron and cancer: Recent insights
-
Manz DH, Blanchette NL, Paul BT, Torti FM, Torti SV. Iron and cancer: Recent insights. Ann NY Acad Sci. 2016; 1368:149–161.
-
(2016)
Ann NY Acad Sci.
, vol.1368
, pp. 149-161
-
-
Manz, D.H.1
Blanchette, N.L.2
Paul, B.T.3
Torti, F.M.4
Torti, S.V.5
-
114
-
-
77955607931
-
Ferroportin and iron regulation in breast cancer progression and prognosis
-
Pinnix ZK, Miller LD, Wang W, et al. Ferroportin and iron regulation in breast cancer progression and prognosis. Sci Transl Med. 2010; 2:43ra56.
-
(2010)
Sci Transl Med.
, vol.2
, pp. 43ra56
-
-
Pinnix, Z.K.1
Miller, L.D.2
Wang, W.3
-
115
-
-
65449117261
-
Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: A meta-analysis of randomised trials
-
Bohlius J, Schmidlin K, Brillant C, et al. Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: A meta-analysis of randomised trials. Lancet. 2009; 373:1532–1542.
-
(2009)
Lancet.
, vol.373
, pp. 1532-1542
-
-
Bohlius, J.1
Schmidlin, K.2
Brillant, C.3
-
116
-
-
70949108082
-
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease
-
Pfeffer MA, Burdmann EA, Chen CY, et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med. 2009; 361:2019–2032.
-
(2009)
N Engl J Med.
, vol.361
, pp. 2019-2032
-
-
Pfeffer, M.A.1
Burdmann, E.A.2
Chen, C.Y.3
-
117
-
-
0027324385
-
Increase in bleomycin-detectable iron in ischaemia/reperfusion injury to rat kidneys
-
Baliga R, Ueda N, Shah SV. Increase in bleomycin-detectable iron in ischaemia/reperfusion injury to rat kidneys. Biochem J. 1993; 291:901–905.
-
(1993)
Biochem J.
, vol.291
, pp. 901-905
-
-
Baliga, R.1
Ueda, N.2
Shah, S.V.3
-
118
-
-
0031933285
-
In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity
-
Baliga R, Zhang Z, Baliga M, Ueda N, Shah SV. In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int. 1998; 53:394–401.
-
(1998)
Kidney Int.
, vol.53
, pp. 394-401
-
-
Baliga, R.1
Zhang, Z.2
Baliga, M.3
Ueda, N.4
Shah, S.V.5
-
120
-
-
0034748257
-
Iron deposition in renal biopsy specimens from patients with kidney diseases
-
Wang H, Nishiya K, Ito H, Hosokawa T, Hashimoto K, Moriki T. Iron deposition in renal biopsy specimens from patients with kidney diseases. Am J Kidney Dis. 2001; 38:1038–1044.
-
(2001)
Am J Kidney Dis.
, vol.38
, pp. 1038-1044
-
-
Wang, H.1
Nishiya, K.2
Ito, H.3
Hosokawa, T.4
Hashimoto, K.5
Moriki, T.6
-
121
-
-
84885094738
-
Increased renal iron accumulation in hypertensive nephropathy of salt-loaded hypertensive rats
-
Naito Y, Sawada H, Oboshi M, et al. Increased renal iron accumulation in hypertensive nephropathy of salt-loaded hypertensive rats. PLoS One. 2013; 8:e75906.
-
(2013)
PLoS One.
, vol.8
-
-
Naito, Y.1
Sawada, H.2
Oboshi, M.3
-
122
-
-
84913582286
-
Synchronized renal tubular cell death involves ferroptosis
-
Linkermann A, Skouta R, Himmerkus N, et al. Synchronized renal tubular cell death involves ferroptosis. Proc Natl Acad Sci USA. 2014; 111:16836–16841.
-
(2014)
Proc Natl Acad Sci USA.
, vol.111
, pp. 16836-16841
-
-
Linkermann, A.1
Skouta, R.2
Himmerkus, N.3
-
123
-
-
84937979950
-
Hepcidin mitigates renal ischemia-reperfusion injury by modulating systemic iron homeostasis
-
Scindia Y, Dey P, Thirunagari A, et al. Hepcidin mitigates renal ischemia-reperfusion injury by modulating systemic iron homeostasis. J Am Soc Nephrol. 2015; 26:2800–2814.
-
(2015)
J Am Soc Nephrol.
, vol.26
, pp. 2800-2814
-
-
Scindia, Y.1
Dey, P.2
Thirunagari, A.3
-
124
-
-
0023774805
-
Role of iron in postischemic renal injury in the rat
-
Paller MS, Hedlund BE. Role of iron in postischemic renal injury in the rat. Kidney Int. 1988; 34:474–480.
-
(1988)
Kidney Int.
, vol.34
, pp. 474-480
-
-
Paller, M.S.1
Hedlund, B.E.2
-
125
-
-
84885045002
-
Proximal tubule H-ferritin mediates iron trafficking in acute kidney injury
-
Zarjou A, Bolisetty S, Joseph R, et al. Proximal tubule H-ferritin mediates iron trafficking in acute kidney injury. J Clin Invest. 2013; 123:4423–4434.
-
(2013)
J Clin Invest.
, vol.123
, pp. 4423-4434
-
-
Zarjou, A.1
Bolisetty, S.2
Joseph, R.3
-
126
-
-
33746552172
-
Heme oxygenase-1: A provenance for cytoprotective pathways in the kidney and other tissues
-
Nath KA. Heme oxygenase-1: A provenance for cytoprotective pathways in the kidney and other tissues. Kidney Int. 2006; 70:432–443.
-
(2006)
Kidney Int.
, vol.70
, pp. 432-443
-
-
Nath, K.A.1
-
127
-
-
84988354702
-
Combined iron sucrose and protoporphyrin treatment protects against ischemic and toxin-mediated acute renal failure
-
Zager RA, Johnson AC, Frostad KB. Combined iron sucrose and protoporphyrin treatment protects against ischemic and toxin-mediated acute renal failure. Kidney Int. 2016; 90:67–76.
-
(2016)
Kidney Int.
, vol.90
, pp. 67-76
-
-
Zager, R.A.1
Johnson, A.C.2
Frostad, K.B.3
-
128
-
-
29044450387
-
Bone mineral density in men with genetic hemochromatosis and HFE gene mutation
-
Guggenbuhl P, Deugnier Y, Boisdet JF, et al. Bone mineral density in men with genetic hemochromatosis and HFE gene mutation. Osteoporos Int. 2005; 16:1809–1814.
-
(2005)
Osteoporos Int.
, vol.16
, pp. 1809-1814
-
-
Guggenbuhl, P.1
Deugnier, Y.2
Boisdet, J.F.3
-
129
-
-
61849146917
-
Bone disease in thalassemia: A frequent and still unresolved problem
-
Vogiatzi MA, Macklin EA, Fung EB, et al. Bone disease in thalassemia: A frequent and still unresolved problem. J Bone Miner Res. 2009; 24:543–557.
-
(2009)
J Bone Miner Res.
, vol.24
, pp. 543-557
-
-
Vogiatzi, M.A.1
Macklin, E.A.2
Fung, E.B.3
-
130
-
-
0042383381
-
Bone histomorphometry in children and adolescents with beta-thalassemia disease: Iron-associated focal osteomalacia
-
Mahachoklertwattana P, Sirikulchayanonta V, Chuansumrit A, et al. Bone histomorphometry in children and adolescents with beta-thalassemia disease: Iron-associated focal osteomalacia. J Clin Endocrinol Metab. 2003; 88:3966–3972.
-
(2003)
J Clin Endocrinol Metab.
, vol.88
, pp. 3966-3972
-
-
Mahachoklertwattana, P.1
Sirikulchayanonta, V.2
Chuansumrit, A.3
-
132
-
-
84946130633
-
Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production
-
David V, Martin A, Isakova T, et al. Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production. Kidney Int. 2016; 89:135–146.
-
(2016)
Kidney Int.
, vol.89
, pp. 135-146
-
-
David, V.1
Martin, A.2
Isakova, T.3
-
133
-
-
81755163635
-
Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice
-
Farrow EG, Yu X, Summers LJ, et al. Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice. Proc Natl Acad Sci USA. 2011; 108:E1146–E1155.
-
(2011)
Proc Natl Acad Sci USA.
, vol.108
, pp. E1146-E1155
-
-
Farrow, E.G.1
Yu, X.2
Summers, L.J.3
-
134
-
-
80655147297
-
Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans
-
Imel EA, Peacock M, Gray AK, et al. Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans. J Clin Endocrinol Metab. 2011; 96:3541–3549.
-
(2011)
J Clin Endocrinol Metab.
, vol.96
, pp. 3541-3549
-
-
Imel, E.A.1
Peacock, M.2
Gray, A.K.3
-
135
-
-
84937979159
-
Iron homeostasis in host defence and inflammation
-
Ganz T, Nemeth E. Iron homeostasis in host defence and inflammation. Nat Rev Immunol. 2015; 15:500–510.
-
(2015)
Nat Rev Immunol.
, vol.15
, pp. 500-510
-
-
Ganz, T.1
Nemeth, E.2
-
136
-
-
84920905125
-
Hepcidin-induced hypoferremia is a critical host defense mechanism against the siderophilic bacterium Vibrio vulnificus
-
Arezes J, Jung G, Gabayan V, et al. Hepcidin-induced hypoferremia is a critical host defense mechanism against the siderophilic bacterium Vibrio vulnificus. Cell Host Microbe. 2015; 17:47–57.
-
(2015)
Cell Host Microbe.
, vol.17
, pp. 47-57
-
-
Arezes, J.1
Jung, G.2
Gabayan, V.3
-
137
-
-
30444459334
-
Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: Community-based, randomised, placebo-controlled trial
-
Sazawal S, Black RE, Ramsan M, et al. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: Community-based, randomised, placebo-controlled trial. Lancet. 2006; 367:133–143.
-
(2006)
Lancet.
, vol.367
, pp. 133-143
-
-
Sazawal, S.1
Black, R.E.2
Ramsan, M.3
-
138
-
-
84879888176
-
Effect of provision of daily zinc and iron with several micronutrients on growth and morbidity among young children in Pakistan: A cluster-randomised trial
-
Soofi S, Cousens S, Iqbal SP, et al. Effect of provision of daily zinc and iron with several micronutrients on growth and morbidity among young children in Pakistan: A cluster-randomised trial. Lancet. 2013; 382:29–40.
-
(2013)
Lancet.
, vol.382
, pp. 29-40
-
-
Soofi, S.1
Cousens, S.2
Iqbal, S.P.3
-
139
-
-
0018166595
-
The adverse effect of iron repletion on the course of certain infections
-
Murray MJ, Murray AB, Murray MB, Murray CJ. The adverse effect of iron repletion on the course of certain infections. Br Med J. 1978; 2:1113–1135.
-
(1978)
Br Med J.
, vol.2
, pp. 1113-1135
-
-
Murray, M.J.1
Murray, A.B.2
Murray, M.B.3
Murray, C.J.4
-
140
-
-
84943144463
-
Rapidly escalating hepcidin and associated serum iron starvation are features of the acute response to typhoid infection in humans
-
Darton TC, Blohmke CJ, Giannoulatou E, et al. Rapidly escalating hepcidin and associated serum iron starvation are features of the acute response to typhoid infection in humans. PLoS Negl Trop Dis. 2015; 9:e0004029.
-
(2015)
PLoS Negl Trop Dis.
, vol.9
-
-
Darton, T.C.1
Blohmke, C.J.2
Giannoulatou, E.3
-
141
-
-
84898042156
-
Inverse agonist of estrogen-related receptor γ controls Salmonella typhimurium infection by modulating host iron homeostasis
-
Kim DK, Jeong JH, Lee JM, et al. Inverse agonist of estrogen-related receptor γ controls Salmonella typhimurium infection by modulating host iron homeostasis. Nat Med. 2014; 20:419–424.
-
(2014)
Nat Med.
, vol.20
, pp. 419-424
-
-
Kim, D.K.1
Jeong, J.H.2
Lee, J.M.3
-
142
-
-
70449394604
-
Selective modulation of TLR4-activated inflammatory responses by altered iron homeostasis in mice
-
Wang L, Harrington L, Trebicka E, et al. Selective modulation of TLR4-activated inflammatory responses by altered iron homeostasis in mice. J Clin Invest. 2009; 119:3322–3328.
-
(2009)
J Clin Invest.
, vol.119
, pp. 3322-3328
-
-
Wang, L.1
Harrington, L.2
Trebicka, E.3
-
143
-
-
79960681867
-
Low hepcidin accounts for the proinflammatory status associated with iron deficiency
-
Pagani A, Nai A, Corna G, et al. Low hepcidin accounts for the proinflammatory status associated with iron deficiency. Blood. 2011; 118:736–746.
-
(2011)
Blood.
, vol.118
, pp. 736-746
-
-
Pagani, A.1
Nai, A.2
Corna, G.3
-
145
-
-
84973130364
-
Conference Participants. Iron management in chronic kidney disease: Conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) controversies conference
-
Macdougall IC, Bircher AJ, Eckardt KU, et al. Conference Participants. Iron management in chronic kidney disease: Conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) controversies conference. Kidney Int. 2016; 89:28–39.
-
(2016)
Kidney Int.
, vol.89
, pp. 28-39
-
-
Macdougall, I.C.1
Bircher, A.J.2
Eckardt, K.U.3
|